Regulation A · Tier 1 · CBDL
CBD Life Sciences Inc.
CBD Life Sciences Inc. (CBDL) filed a Tier 1 Regulation A offering statement (Form 1-A) on May 2, 2024 for up to $10.1M at $0.0022 per security. The SEC qualified the offering on Jun 21, 2024.
- Status
- Qualified
- Tier
- Tier 1
- Offering size
- $10.1M
- Offer price
- $0.0022
- Security type
- Equity (common or preferred stock)
- Filed
- May 2, 2024
- Qualified
- Jun 21, 2024
- Ticker
- CBDL
- Exchange
- OTC
- Industry
- Medicinal Chemicals & Botanical Products
- State
- AZ
More on this offering for subscribers
- Revenue, net income and total assets from the offering statement
- Employees
- Market cap at the offer price
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Offering statement (Form 1-A) May 2, 2024
- Final offering circular (253G2)
- All filings on EDGAR CIK 1776073
Other qualified Biotech & pharma Reg A offerings
- Regen BioPharma IncDec 10, 2024 · $0
- BirchBioMed Inc.Oct 8, 2024 · $10M
- Bioquest CorpAug 21, 2024 · $10M
- Adia Med, Inc.Jun 21, 2024 · $938K
- CancerVAX, Inc.Mar 22, 2024 · $5M
- IntelGenx Technologies Corp.Feb 16, 2024 · $20M